Witnessing the stock’s movement on the chart, on Thursday, Applied Therapeutics Inc (NASDAQ: APLT) had a quiet start as it plunged -5.92% to $0.1, before settling in for the price of $0.11 at the close. Taking a more long-term approach, APLT posted a 52-week range of $0.09-$1.50.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 26.57%. Meanwhile, its Annual Earning per share during the time was 26.57%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 29.93%. This publicly-traded company’s shares outstanding now amounts to $144.30 million, simultaneously with a float of $133.23 million. The organization now has a market capitalization sitting at $14.46 million. At the time of writing, stock’s 50-day Moving Average stood at $0.3793, while the 200-day Moving Average is $0.4897.
Applied Therapeutics Inc (APLT) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Applied Therapeutics Inc’s current insider ownership accounts for 7.67%, in contrast to 62.03% institutional ownership. According to the most recent insider trade that took place on Dec 16 ’25, this organization’s Director sold 43,000 shares at the rate of 0.11, making the entire transaction reach 4,816 in total value, affecting insider ownership by 65,000.
Applied Therapeutics Inc (APLT) Earnings and Revenue Records
Applied Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 29.93% and is forecasted to reach -0.43 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 33.95% through the next 5 years, which can be compared against the 26.57% growth it accomplished over the previous five years trading on the market.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Let’s observe the current performance indicators for Applied Therapeutics Inc (APLT). It’s Quick Ratio in the last reported quarter now stands at 0.96. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 14.46.
In the same vein, APLT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.10, a figure that is expected to reach -0.12 in the next quarter, and analysts are predicting that it will be -0.43 at the market close of one year from today.
Technical Analysis of Applied Therapeutics Inc (APLT)
Going through the that latest performance of [Applied Therapeutics Inc, APLT]. Its last 5-days volume of 5.87 million indicated improvement to the volume of 5.87 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 39.70% While, its Average True Range was 26.09.
Raw Stochastic average of Applied Therapeutics Inc (APLT) in the period of the previous 100 days is set at 0.65%, which indicates a major fall in contrast to 20.82% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0111 that was lower than 0.0806 volatility it exhibited in the past 100-days period.
